Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade (Q72507690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

27 October 2019

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

8 August 2023

1

W H Frishman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

J. A. Strom

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

M. Kirschner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

M. Poland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

N. Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

S. Halprin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

T. H. LeJemtel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

M. Kram

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

E. H. Sonnenblick

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118060

8 August 2023

language of work or name

English

0 references

publication date

1 November 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://api.elsevier.com/content/article/PII:0002914981903593?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

https://api.elsevier.com/content/article/PII:0002914981903593?httpAccept=text/plain

8 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

American Journal of Cardiology

8 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

917-928

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects

27 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications

8 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: Labetalol

8 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects

8 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Effects of Alpha Adrenergic Blockade upon Coronary Hemodynamics

8 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease

8 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

8 August 2023

Coronary-Artery Spasm

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

8 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Labetalol in long-term treatment of hypertension

8 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Pharmacological basis for antihypertensive effects of intravenous labetalol

8 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Labetalol: a review of its pharmacology and therapeutic use in hypertension

8 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients

8 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Controlled comparison of labetalol and propranolol in the management of severe hypertension

8 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Relationship between plasma concentrations and pharmacological effects of labetalol

8 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

8 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Bedside technics for the evaluation of ventricular function in man

8 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

A critical review of the systolic time intervals

8 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Noninvasive assessment of clinical response to oral propranolol therapy

8 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

8 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

EFFECT OF ADENOSINE NUCLEOTIDES ON PLATELET AGGREGATION AND CLOTTING TIME

8 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral Propranolol

8 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension

8 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Labetalol in resistant hypertension

8 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Haemodynamic effects of long-term oral labetalol

8 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease

8 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Haemodynamic studies in hypertensive patients treated by oral propranolol

8 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Hypertension: which beta-blocker?

8 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity

8 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

The Antidiuretic Action of Diazoxide

8 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release

8 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight

8 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Relationships between membrane cholesterol, α-adrenergic receptors, and platelet function

8 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding

8 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise

8 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Evaluation of Left Ventricular Function by Echocardiography

8 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Left Ventricular Volumes and Ejection Fraction by Echocardiography

8 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

The effects of phentolamine on the duration of the phases of ventricular systole in man

8 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Coronary artery syndromes after sudden propranolol withdrawal

8 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

8 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties

8 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Relationship between plasma concentrations and pharmacological effects of labetalol

8 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs

8 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation

8 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

alpha-Adrenoceptor attenuation of the coronary vascular response to severe exercise in the conscious dog

8 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

An evaluation of the coronary constriction following propranolol

8 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Regulation of coronary blood flow

8 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Coronary spasm and acute myocardial infarction--new possibility for treatment and prevention

8 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Therapy of coronary vasoconstriction in patients with coronary artery disease.

8 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

The effects of a new alpha- and beta-adrenoceptor antagonist (AH5158) upon the general and coronary haemodynamics of intact dogs

8 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

Protective effects of simultaneous alpha and beta adrenergic receptor blockade on myocardial cell necrosis after coronary arterial occlusion in rats

8 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-9149(81)90359-3

8 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6118060%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference